| Literature DB >> 31852820 |
Cailing Liu1,2, Taiga Miyajima1,2, Geetha Melangath1,2, Takashi Miyai1,2, Shivakumar Vasanth1,2, Neha Deshpande1,2, Varun Kumar1,2, Stephan Ong Tone1,2, Reena Gupta1,2, Shan Zhu1,2, Dijana Vojnovic1,2, Yuming Chen1,2, Eleanor G Rogan3, Bodhiswatta Mondal3, Muhammad Zahid3, Ula V Jurkunas4,2.
Abstract
Fuchs endothelial corneal dystrophy (FECD) is a leading cause of corneal endothelial (CE) degeneration resulting in impaired visual acuity. It is a genetically complex and age-related disorder, with higher incidence in females. In this study, we established a nongenetic FECD animal model based on the physiologic outcome of CE susceptibility to oxidative stress by demonstrating that corneal exposure to ultraviolet A (UVA) recapitulates the morphological and molecular changes of FECD. Targeted irradiation of mouse corneas with UVA induced reactive oxygen species (ROS) production in the aqueous humor, and caused greater CE cell loss, including loss of ZO-1 junctional contacts and corneal edema, in female than male mice, characteristic of late-onset FECD. UVA irradiation caused greater mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) damage in female mice, indicative of the sex-driven differential response of the CE to UVA, thus accounting for more severe phenotype in females. The sex-dependent effect of UVA was driven by the activation of estrogen-metabolizing enzyme CYP1B1 and formation of reactive estrogen metabolites and estrogen-DNA adducts in female but not male mice. Supplementation of N-acetylcysteine (NAC), a scavenger of reactive oxygen species (ROS), diminished the morphological and molecular changes induced by UVA in vivo. This study investigates the molecular mechanisms of environmental factors in FECD pathogenesis and demonstrates a strong link between UVA-induced estrogen metabolism and increased susceptibility of females for FECD development.Entities:
Keywords: CYP1B1; Fuchs endothelial corneal dystrophy; estrogen metabolism; mitochondrial DNA damage; ultraviolet light
Mesh:
Substances:
Year: 2019 PMID: 31852820 PMCID: PMC6955350 DOI: 10.1073/pnas.1912546116
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205